Drug
Asenapine clinical trials
Also written Org 5222, Saphris and SCH 900274.
- studies test it
- 42
- open now
- 0
- in phase 3
- 32
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
Development codes
- Org 5222
- 11
Studies by the year they started
42 studies that test it; most in 2005 (13)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 13 |
| 2006 | 1 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 9 |
| 2013 | 3 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 3
- 32
- Phase 4
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 34 · Other 8
Organon and Co (29) · Forest Laboratories (3) · Duke University (2) · Sun Pharmaceutical Industries Limited (1) · Noven Pharmaceuticals, Inc. (1) · Lori Davis, MD (1) · Unity Health Toronto (1) · University Hospitals Cleveland Medical Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses asenapine is read from its arms, and is right about nine times in ten.
Testing it · 42
- 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)CompletedPhase 3Organon and CoNCT00143182Written as Asenapine
- An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)CompletedPhase 2Organon and CoNCT00878462Written as Asenapine WHITE raspberry flavor (Treatment A)
- 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)CompletedPhase 3Organon and CoNCT00159744Written as Asenapine
- Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)CompletedPhase 3Organon and CoNCT00156104Written as Asenapine
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)CompletedPhase 3Organon and CoNCT00151424Written as asenapine
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)CompletedPhase 3Organon and CoNCT00156117Written as asenapine
- 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)CompletedPhase 3Organon and CoNCT00159796Written as Asenapine
- Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)CompletedPhase 3Organon and CoNCT00212836Written as asenapine
- Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)CompletedPhase 3Organon and CoNCT00212784Written as asenapine
- 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)CompletedPhase 3Organon and CoNCT01098110Written as Asenapine 5 mg
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)CompletedPhase 3Organon and CoNCT01244815Written as asenapine
- A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)CompletedPhase 3Organon and CoNCT01617187Written as Asenapine
- Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)CompletedPhase 3Organon and CoNCT00764478Written as Asenapine
- Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)CompletedPhase 3Organon and CoNCT01142596Written as Asenapine
- Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)CompletedPhase 3Organon and CoNCT01244828Written as Asenapine
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)CompletedPhase 1Organon and CoNCT01206517Written as Asenapine 2.5 mg
- Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)CompletedPhase 3Organon and CoNCT01190267Written as asenapine
- Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)CompletedPhase 3Organon and CoNCT01349907Written as Asenapine
- 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)CompletedPhase 3Organon and CoNCT00145470Written as Asenapine
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)CompletedPhase 3Organon and CoNCT01190254Written as asenapine 2.5 mg
Codes
What other systems call asenapine · ClinicalTrials.gg INT005152
- MeSH (NLM) C522667asenapineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JKZ19V908OASENAPINEConfirmed FDA, NLM, Wikidata
- RxNorm 784649One source FDA
- Wikidata Q27074536(S,S)-asenapineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72705AsenapineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C522667 | asenapine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JKZ19V908O | ASENAPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 784649 | — | One source FDA |
| Wikidata | Q27074536 | (S,S)-asenapine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72705 | Asenapine | One source FDA |
Also registered as asenapine maleate (UNII CU9463U2E2 · RxNorm 860647).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.